nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.318	1	CiPCiCtD
Amcinonide—Prednisone—prostate cancer	0.218	1	CrCtD
Amcinonide—ANXA1—prostate cancer	0.196	0.809	CbGaD
Amcinonide—NR3C1—prostate cancer	0.0464	0.191	CbGaD
Amcinonide—NR3C1—Prednisone—prostate cancer	0.0158	1	CbGbCtD
Amcinonide—Ciclesonide—Prednisone—prostate cancer	0.0107	0.0752	CrCrCtD
Amcinonide—Cortisone acetate—Prednisone—prostate cancer	0.0087	0.061	CrCrCtD
Amcinonide—Prednicarbate—Prednisone—prostate cancer	0.00844	0.0591	CrCrCtD
Amcinonide—Budesonide—Prednisone—prostate cancer	0.00776	0.0544	CrCrCtD
Amcinonide—Flunisolide—Prednisone—prostate cancer	0.00756	0.053	CrCrCtD
Amcinonide—Clobetasol propionate—Prednisone—prostate cancer	0.00756	0.053	CrCrCtD
Amcinonide—Fludrocortisone—Prednisone—prostate cancer	0.00756	0.053	CrCrCtD
Amcinonide—Desonide—Prednisone—prostate cancer	0.00756	0.053	CrCrCtD
Amcinonide—Diflorasone—Prednisone—prostate cancer	0.00756	0.053	CrCrCtD
Amcinonide—Desoximetasone—Prednisone—prostate cancer	0.00719	0.0504	CrCrCtD
Amcinonide—Loteprednol—Prednisone—prostate cancer	0.00702	0.0492	CrCrCtD
Amcinonide—Fluorometholone—Prednisone—prostate cancer	0.00702	0.0492	CrCrCtD
Amcinonide—Triamcinolone—Prednisone—prostate cancer	0.00702	0.0492	CrCrCtD
Amcinonide—Mometasone—Prednisone—prostate cancer	0.00702	0.0492	CrCrCtD
Amcinonide—Fluprednidene Acetate—Prednisone—prostate cancer	0.00702	0.0492	CrCrCtD
Amcinonide—Betamethasone—Prednisone—prostate cancer	0.00686	0.0481	CrCrCtD
Amcinonide—Dexamethasone—Prednisone—prostate cancer	0.00686	0.0481	CrCrCtD
Amcinonide—Rimexolone—Prednisone—prostate cancer	0.00686	0.0481	CrCrCtD
Amcinonide—Prednisolone—Prednisone—prostate cancer	0.00642	0.045	CrCrCtD
Amcinonide—ANXA1—prostate gland—prostate cancer	0.00159	0.125	CbGeAlD
Amcinonide—NR3C1—urine—prostate cancer	0.00154	0.121	CbGeAlD
Amcinonide—ANXA1—seminal vesicle—prostate cancer	0.00135	0.106	CbGeAlD
Amcinonide—ANXA1—epithelium—prostate cancer	0.00117	0.0921	CbGeAlD
Amcinonide—ANXA1—renal system—prostate cancer	0.00109	0.0854	CbGeAlD
Amcinonide—ANXA1—urethra—prostate cancer	0.00107	0.0839	CbGeAlD
Amcinonide—ANXA1—bone marrow—prostate cancer	0.000821	0.0646	CbGeAlD
Amcinonide—Tenderness—Estramustine—prostate cancer	0.000708	0.0446	CcSEcCtD
Amcinonide—ANXA1—testis—prostate cancer	0.000702	0.0552	CbGeAlD
Amcinonide—Secondary adrenocortical insufficiency—Prednisone—prostate cancer	0.000699	0.044	CcSEcCtD
Amcinonide—Tenderness—Estrone—prostate cancer	0.000677	0.0426	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Estradiol—prostate cancer	0.000625	0.0394	CcSEcCtD
Amcinonide—Tenderness—Estradiol valerate/Dienogest—prostate cancer	0.000591	0.0372	CcSEcCtD
Amcinonide—NR3C1—prostate gland—prostate cancer	0.000553	0.0435	CbGeAlD
Amcinonide—Telangiectasia—Prednisone—prostate cancer	0.000515	0.0324	CcSEcCtD
Amcinonide—ANXA1—lymph node—prostate cancer	0.000509	0.04	CbGeAlD
Amcinonide—Acneiform eruption—Prednisone—prostate cancer	0.00048	0.0302	CcSEcCtD
Amcinonide—NR3C1—seminal vesicle—prostate cancer	0.000468	0.0368	CbGeAlD
Amcinonide—Cataract subcapsular—Prednisone—prostate cancer	0.000465	0.0293	CcSEcCtD
Amcinonide—Tenderness—Bicalutamide—prostate cancer	0.000454	0.0286	CcSEcCtD
Amcinonide—NR3C1—epithelium—prostate cancer	0.000407	0.032	CbGeAlD
Amcinonide—Skin atrophy—Prednisone—prostate cancer	0.000402	0.0253	CcSEcCtD
Amcinonide—Skin striae—Prednisone—prostate cancer	0.000381	0.024	CcSEcCtD
Amcinonide—NR3C1—renal system—prostate cancer	0.000377	0.0297	CbGeAlD
Amcinonide—Atrophy—Prednisone—prostate cancer	0.000372	0.0234	CcSEcCtD
Amcinonide—NR3C1—urethra—prostate cancer	0.00037	0.0291	CbGeAlD
Amcinonide—Dermatitis acneiform—Prednisone—prostate cancer	0.000355	0.0224	CcSEcCtD
Amcinonide—Secondary infection—Epirubicin—prostate cancer	0.000323	0.0203	CcSEcCtD
Amcinonide—Hypertrichosis—Prednisone—prostate cancer	0.000319	0.0201	CcSEcCtD
Amcinonide—Tenderness—Goserelin—prostate cancer	0.000316	0.0199	CcSEcCtD
Amcinonide—Tenderness—Conjugated Estrogens—prostate cancer	0.000313	0.0197	CcSEcCtD
Amcinonide—Secondary infection—Doxorubicin—prostate cancer	0.000299	0.0188	CcSEcCtD
Amcinonide—Leukoderma—Prednisone—prostate cancer	0.000285	0.018	CcSEcCtD
Amcinonide—NR3C1—bone marrow—prostate cancer	0.000285	0.0224	CbGeAlD
Amcinonide—Tenderness—Estradiol—prostate cancer	0.00025	0.0158	CcSEcCtD
Amcinonide—NR3C1—testis—prostate cancer	0.000244	0.0192	CbGeAlD
Amcinonide—Leukoderma—Epirubicin—prostate cancer	0.000223	0.0141	CcSEcCtD
Amcinonide—Dermatitis contact—Estradiol—prostate cancer	0.000216	0.0136	CcSEcCtD
Amcinonide—Infection—Abiraterone—prostate cancer	0.000213	0.0134	CcSEcCtD
Amcinonide—Leukoderma—Doxorubicin—prostate cancer	0.000206	0.013	CcSEcCtD
Amcinonide—Pain—Estrone—prostate cancer	0.00018	0.0113	CcSEcCtD
Amcinonide—NR3C1—lymph node—prostate cancer	0.000177	0.0139	CbGeAlD
Amcinonide—Pain—Nilutamide—prostate cancer	0.000167	0.0105	CcSEcCtD
Amcinonide—Infection—Cabazitaxel—prostate cancer	0.000164	0.0103	CcSEcCtD
Amcinonide—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000157	0.0099	CcSEcCtD
Amcinonide—Pruritus—Estramustine—prostate cancer	0.000156	0.00983	CcSEcCtD
Amcinonide—Folliculitis—Epirubicin—prostate cancer	0.000151	0.0095	CcSEcCtD
Amcinonide—Pain—Degarelix—prostate cancer	0.000149	0.00941	CcSEcCtD
Amcinonide—Pruritus—Estrone—prostate cancer	0.000149	0.00939	CcSEcCtD
Amcinonide—Pain—Cabazitaxel—prostate cancer	0.000141	0.00887	CcSEcCtD
Amcinonide—Infection—Bicalutamide—prostate cancer	0.00014	0.00884	CcSEcCtD
Amcinonide—Folliculitis—Doxorubicin—prostate cancer	0.00014	0.00879	CcSEcCtD
Amcinonide—Dermatitis—Estramustine—prostate cancer	0.000139	0.00875	CcSEcCtD
Amcinonide—Pruritus—Nilutamide—prostate cancer	0.000138	0.00872	CcSEcCtD
Amcinonide—Pruritus—Flutamide—prostate cancer	0.000138	0.00868	CcSEcCtD
Amcinonide—Dermatitis—Abiraterone—prostate cancer	0.000135	0.0085	CcSEcCtD
Amcinonide—Dermatitis—Estrone—prostate cancer	0.000133	0.00836	CcSEcCtD
Amcinonide—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00013	0.00819	CcSEcCtD
Amcinonide—Pruritus—Degarelix—prostate cancer	0.000124	0.00779	CcSEcCtD
Amcinonide—Dermatitis—Nilutamide—prostate cancer	0.000123	0.00776	CcSEcCtD
Amcinonide—Dermatitis—Flutamide—prostate cancer	0.000123	0.00773	CcSEcCtD
Amcinonide—Pain—Bicalutamide—prostate cancer	0.000121	0.00761	CcSEcCtD
Amcinonide—Rash pustular—Epirubicin—prostate cancer	0.000119	0.00749	CcSEcCtD
Amcinonide—Infection—Ethinyl Estradiol—prostate cancer	0.000119	0.00747	CcSEcCtD
Amcinonide—Stinging—Epirubicin—prostate cancer	0.000117	0.00737	CcSEcCtD
Amcinonide—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000116	0.00729	CcSEcCtD
Amcinonide—Dermatitis—Degarelix—prostate cancer	0.00011	0.00693	CcSEcCtD
Amcinonide—Rash pustular—Doxorubicin—prostate cancer	0.00011	0.00693	CcSEcCtD
Amcinonide—Stinging—Doxorubicin—prostate cancer	0.000108	0.00682	CcSEcCtD
Amcinonide—Pruritus—Bicalutamide—prostate cancer	9.99e-05	0.00629	CcSEcCtD
Amcinonide—Infection—Goserelin—prostate cancer	9.76e-05	0.00615	CcSEcCtD
Amcinonide—Infection—Conjugated Estrogens—prostate cancer	9.67e-05	0.00609	CcSEcCtD
Amcinonide—Dermatitis contact—Epirubicin—prostate cancer	9.37e-05	0.0059	CcSEcCtD
Amcinonide—Dermatitis—Bicalutamide—prostate cancer	8.9e-05	0.0056	CcSEcCtD
Amcinonide—Dermatitis contact—Doxorubicin—prostate cancer	8.67e-05	0.00546	CcSEcCtD
Amcinonide—Pruritus—Ethinyl Estradiol—prostate cancer	8.45e-05	0.00532	CcSEcCtD
Amcinonide—Pain—Goserelin—prostate cancer	8.4e-05	0.00529	CcSEcCtD
Amcinonide—Pain—Conjugated Estrogens—prostate cancer	8.32e-05	0.00524	CcSEcCtD
Amcinonide—Infection—Estradiol—prostate cancer	7.74e-05	0.00487	CcSEcCtD
Amcinonide—Dermatitis—Ethinyl Estradiol—prostate cancer	7.52e-05	0.00474	CcSEcCtD
Amcinonide—Infection—Mitoxantrone—prostate cancer	7.21e-05	0.00454	CcSEcCtD
Amcinonide—Pruritus—Goserelin—prostate cancer	6.95e-05	0.00438	CcSEcCtD
Amcinonide—Pruritus—Conjugated Estrogens—prostate cancer	6.89e-05	0.00434	CcSEcCtD
Amcinonide—Pain—Estradiol—prostate cancer	6.66e-05	0.0042	CcSEcCtD
Amcinonide—Dexamethasone—CYP3A43—prostate cancer	6.47e-05	0.0349	CrCbGaD
Amcinonide—Pain—Mitoxantrone—prostate cancer	6.21e-05	0.00391	CcSEcCtD
Amcinonide—Dermatitis—Goserelin—prostate cancer	6.19e-05	0.0039	CcSEcCtD
Amcinonide—Dermatitis—Conjugated Estrogens—prostate cancer	6.13e-05	0.00386	CcSEcCtD
Amcinonide—Infection—Etoposide—prostate cancer	6e-05	0.00378	CcSEcCtD
Amcinonide—Pruritus—Estradiol—prostate cancer	5.51e-05	0.00347	CcSEcCtD
Amcinonide—Difluprednate—NR3C1—prostate cancer	5.48e-05	0.0295	CrCbGaD
Amcinonide—Prednicarbate—NR3C1—prostate cancer	5.31e-05	0.0286	CrCbGaD
Amcinonide—Pain—Etoposide—prostate cancer	5.16e-05	0.00325	CcSEcCtD
Amcinonide—Dexamethasone—ANXA1—prostate cancer	5.12e-05	0.0276	CrCbGaD
Amcinonide—Diflorasone—NR3C1—prostate cancer	5.02e-05	0.0271	CrCbGaD
Amcinonide—Desonide—NR3C1—prostate cancer	5.02e-05	0.0271	CrCbGaD
Amcinonide—Infection—Docetaxel—prostate cancer	4.98e-05	0.00314	CcSEcCtD
Amcinonide—Dermatitis—Estradiol—prostate cancer	4.91e-05	0.00309	CcSEcCtD
Amcinonide—Desoximetasone—NR3C1—prostate cancer	4.9e-05	0.0264	CrCbGaD
Amcinonide—Loteprednol—NR3C1—prostate cancer	4.84e-05	0.0261	CrCbGaD
Amcinonide—Infection—Capecitabine—prostate cancer	4.83e-05	0.00304	CcSEcCtD
Amcinonide—Fludrocortisone—AR—prostate cancer	4.77e-05	0.0257	CrCbGaD
Amcinonide—Beclomethasone—CYP3A5—prostate cancer	4.58e-05	0.0247	CrCbGaD
Amcinonide—Dermatitis—Mitoxantrone—prostate cancer	4.57e-05	0.00288	CcSEcCtD
Amcinonide—Fluoxymesterone—SHBG—prostate cancer	4.5e-05	0.0243	CrCbGaD
Amcinonide—Infection—Prednisone—prostate cancer	4.3e-05	0.00271	CcSEcCtD
Amcinonide—Pain—Docetaxel—prostate cancer	4.29e-05	0.0027	CcSEcCtD
Amcinonide—Flurandrenolide—NR3C1—prostate cancer	4.29e-05	0.0231	CrCbGaD
Amcinonide—Pruritus—Etoposide—prostate cancer	4.27e-05	0.00269	CcSEcCtD
Amcinonide—Flumethasone Pivalate—NR3C1—prostate cancer	4.22e-05	0.0228	CrCbGaD
Amcinonide—Pain—Capecitabine—prostate cancer	4.15e-05	0.00262	CcSEcCtD
Amcinonide—Halobetasol Propionate—NR3C1—prostate cancer	4.15e-05	0.0224	CrCbGaD
Amcinonide—Cortisone acetate—NR3C1—prostate cancer	4.08e-05	0.022	CrCbGaD
Amcinonide—Fluoxymesterone—AR—prostate cancer	3.94e-05	0.0213	CrCbGaD
Amcinonide—Budesonide—NR3C1—prostate cancer	3.86e-05	0.0208	CrCbGaD
Amcinonide—Dermatitis—Etoposide—prostate cancer	3.8e-05	0.0024	CcSEcCtD
Amcinonide—Fluticasone furoate—NR3C1—prostate cancer	3.78e-05	0.0204	CrCbGaD
Amcinonide—Mometasone—NR3C1—prostate cancer	3.67e-05	0.0198	CrCbGaD
Amcinonide—Rimexolone—NR3C1—prostate cancer	3.63e-05	0.0196	CrCbGaD
Amcinonide—Pruritus—Docetaxel—prostate cancer	3.55e-05	0.00224	CcSEcCtD
Amcinonide—Pruritus—Capecitabine—prostate cancer	3.44e-05	0.00216	CcSEcCtD
Amcinonide—Fluocinonide—NR3C1—prostate cancer	3.42e-05	0.0185	CrCbGaD
Amcinonide—Beclomethasone—NR3C1—prostate cancer	3.42e-05	0.0185	CrCbGaD
Amcinonide—Infection—Epirubicin—prostate cancer	3.36e-05	0.00212	CcSEcCtD
Amcinonide—Fluocinolone Acetonide—NR3C1—prostate cancer	3.32e-05	0.0179	CrCbGaD
Amcinonide—Fludrocortisone—NR3C1—prostate cancer	3.24e-05	0.0175	CrCbGaD
Amcinonide—Flunisolide—NR3C1—prostate cancer	3.24e-05	0.0175	CrCbGaD
Amcinonide—Clobetasol propionate—NR3C1—prostate cancer	3.24e-05	0.0175	CrCbGaD
Amcinonide—Dermatitis—Docetaxel—prostate cancer	3.16e-05	0.00199	CcSEcCtD
Amcinonide—Ciclesonide—NR3C1—prostate cancer	3.14e-05	0.017	CrCbGaD
Amcinonide—Fluorometholone—NR3C1—prostate cancer	3.12e-05	0.0168	CrCbGaD
Amcinonide—Infection—Doxorubicin—prostate cancer	3.11e-05	0.00196	CcSEcCtD
Amcinonide—Pruritus—Prednisone—prostate cancer	3.06e-05	0.00193	CcSEcCtD
Amcinonide—Dermatitis—Capecitabine—prostate cancer	3.06e-05	0.00193	CcSEcCtD
Amcinonide—Fluticasone Propionate—CYP3A5—prostate cancer	3.04e-05	0.0164	CrCbGaD
Amcinonide—Fluoxymesterone—ESR1—prostate cancer	3.04e-05	0.0164	CrCbGaD
Amcinonide—Clobetasol propionate—CYP1A1—prostate cancer	2.94e-05	0.0159	CrCbGaD
Amcinonide—Dexamethasone—CYP17A1—prostate cancer	2.94e-05	0.0159	CrCbGaD
Amcinonide—Pain—Epirubicin—prostate cancer	2.89e-05	0.00182	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—JUP—prostate cancer	2.86e-05	0.000858	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—prostate cancer	2.83e-05	0.000852	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GJA1—prostate cancer	2.81e-05	0.000845	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—prostate cancer	2.81e-05	0.000843	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AR—prostate cancer	2.79e-05	0.000838	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LPL—prostate cancer	2.77e-05	0.000832	CbGpPWpGaD
Amcinonide—Prednisolone—CYP2A6—prostate cancer	2.76e-05	0.0149	CrCbGaD
Amcinonide—Dermatitis—Prednisone—prostate cancer	2.73e-05	0.00172	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—MC2R—prostate cancer	2.72e-05	0.000819	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RALBP1—prostate cancer	2.72e-05	0.000819	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—EP300—prostate cancer	2.71e-05	0.000814	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	2.68e-05	0.000805	CbGpPWpGaD
Amcinonide—Pain—Doxorubicin—prostate cancer	2.68e-05	0.00169	CcSEcCtD
Amcinonide—Fluoxymesterone—NR3C1—prostate cancer	2.67e-05	0.0144	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	2.67e-05	0.000803	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	2.66e-05	0.000799	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—prostate cancer	2.66e-05	0.000798	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PTHLH—prostate cancer	2.65e-05	0.000796	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—SRC—prostate cancer	2.64e-05	0.000792	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—EP300—prostate cancer	2.63e-05	0.000791	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	2.62e-05	0.000788	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PRKACB—prostate cancer	2.59e-05	0.000779	CbGpPWpGaD
Amcinonide—Betamethasone—CYP19A1—prostate cancer	2.57e-05	0.0139	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—CALCA—prostate cancer	2.57e-05	0.000772	CbGpPWpGaD
Amcinonide—Triamcinolone—NR3C1—prostate cancer	2.54e-05	0.0137	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—prostate cancer	2.53e-05	0.00076	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPP3CA—prostate cancer	2.53e-05	0.000759	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL12—prostate cancer	2.51e-05	0.000754	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	2.48e-05	0.000744	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN1B—prostate cancer	2.47e-05	0.000742	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARA—prostate cancer	2.45e-05	0.000735	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—prostate cancer	2.44e-05	0.000732	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PENK—prostate cancer	2.43e-05	0.00073	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL2—prostate cancer	2.42e-05	0.000726	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—BAZ2A—prostate cancer	2.42e-05	0.000726	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SSR2—prostate cancer	2.42e-05	0.000726	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ZNF160—prostate cancer	2.42e-05	0.000726	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	2.42e-05	0.000726	CbGpPWpGaD
Amcinonide—Pruritus—Epirubicin—prostate cancer	2.39e-05	0.00151	CcSEcCtD
Amcinonide—NR3C1—Endoderm Differentiation—CTNNB1—prostate cancer	2.39e-05	0.000718	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	2.38e-05	0.000716	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—prostate cancer	2.38e-05	0.000716	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HIF1A—prostate cancer	2.38e-05	0.000714	CbGpPWpGaD
Amcinonide—Cortisone acetate—CYP3A4—prostate cancer	2.37e-05	0.0128	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCND1—prostate cancer	2.36e-05	0.000708	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CTNNB1—prostate cancer	2.33e-05	0.000701	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CALCA—prostate cancer	2.33e-05	0.000701	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LEP—prostate cancer	2.32e-05	0.000697	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GHR—prostate cancer	2.32e-05	0.000696	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PIK3CA—prostate cancer	2.31e-05	0.000695	CbGpPWpGaD
Amcinonide—Prednisone—NR3C1—prostate cancer	2.31e-05	0.0124	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—PRKCQ—prostate cancer	2.29e-05	0.000688	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—prostate cancer	2.29e-05	0.000688	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL12—prostate cancer	2.28e-05	0.000684	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PTEN—prostate cancer	2.28e-05	0.000684	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	2.27e-05	0.000684	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—NR3C1—prostate cancer	2.27e-05	0.0123	CrCbGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	2.25e-05	0.000677	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	2.24e-05	0.000674	CbGpPWpGaD
Amcinonide—Budesonide—CYP3A4—prostate cancer	2.24e-05	0.0121	CrCbGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—prostate cancer	2.23e-05	0.00067	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRP1—prostate cancer	2.22e-05	0.000667	CbGpPWpGaD
Amcinonide—Pruritus—Doxorubicin—prostate cancer	2.22e-05	0.0014	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—HNRNPH1—prostate cancer	2.21e-05	0.000664	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.2e-05	0.000661	CbGpPWpGaD
Amcinonide—Fluticasone furoate—CYP3A4—prostate cancer	2.19e-05	0.0118	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—EP300—prostate cancer	2.17e-05	0.000652	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRB2—prostate cancer	2.15e-05	0.000647	CbGpPWpGaD
Amcinonide—Dermatitis—Epirubicin—prostate cancer	2.13e-05	0.00134	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	2.13e-05	0.00064	CbGpPWpGaD
Amcinonide—Prednisolone—NR3C1—prostate cancer	2.13e-05	0.0115	CrCbGaD
Amcinonide—Prednisone—CYP2C19—prostate cancer	2.1e-05	0.0113	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—VAV3—prostate cancer	2.1e-05	0.000631	CbGpPWpGaD
Amcinonide—Betamethasone—NR3C1—prostate cancer	2.08e-05	0.0112	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—PRKCQ—prostate cancer	2.08e-05	0.000625	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IRS1—prostate cancer	2.07e-05	0.000622	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	2.07e-05	0.000622	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VIP—prostate cancer	2.07e-05	0.00062	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GNRH1—prostate cancer	2.07e-05	0.00062	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NFIC—prostate cancer	2.06e-05	0.000618	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	2.05e-05	0.000617	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP1B1—prostate cancer	2.04e-05	0.011	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—ITPR1—prostate cancer	2.04e-05	0.000612	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	2.03e-05	0.00061	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	2.01e-05	0.000604	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LPAR1—prostate cancer	2e-05	0.000601	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRP—prostate cancer	2e-05	0.000601	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—INS—prostate cancer	1.98e-05	0.000596	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLCB2—prostate cancer	1.98e-05	0.000595	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LRP2—prostate cancer	1.98e-05	0.000595	CbGpPWpGaD
Amcinonide—Dermatitis—Doxorubicin—prostate cancer	1.97e-05	0.00124	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—ADRB2—prostate cancer	1.95e-05	0.000587	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—P4HB—prostate cancer	1.94e-05	0.000583	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CX3CL1—prostate cancer	1.94e-05	0.000583	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPN2—prostate cancer	1.93e-05	0.000581	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	1.93e-05	0.00058	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	1.93e-05	0.00058	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IGF1—prostate cancer	1.92e-05	0.000576	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	1.91e-05	0.000574	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—VAV3—prostate cancer	1.91e-05	0.000573	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIST1H2BG—prostate cancer	1.91e-05	0.000573	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	1.9e-05	0.000571	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	1.89e-05	0.000568	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRB7—prostate cancer	1.89e-05	0.000567	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDE4D—prostate cancer	1.89e-05	0.000567	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	1.89e-05	0.000567	CbGpPWpGaD
Amcinonide—Flunisolide—CYP3A4—prostate cancer	1.88e-05	0.0101	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.86e-05	0.000558	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	1.86e-05	0.000558	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ITPR1—prostate cancer	1.85e-05	0.000555	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIST1H4H—prostate cancer	1.84e-05	0.000553	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—prostate cancer	1.84e-05	0.000553	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	1.83e-05	0.000551	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—QARS—prostate cancer	1.83e-05	0.00055	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	1.83e-05	0.000549	CbGpPWpGaD
Amcinonide—Ciclesonide—CYP3A4—prostate cancer	1.82e-05	0.00983	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—SERPINE1—prostate cancer	1.82e-05	0.000547	CbGpPWpGaD
Amcinonide—Fluorometholone—CYP3A4—prostate cancer	1.81e-05	0.00976	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—GNG5—prostate cancer	1.8e-05	0.00054	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	1.68e-05	0.000505	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	1.68e-05	0.000504	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TBX5—prostate cancer	1.68e-05	0.000503	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP3A5—prostate cancer	1.62e-05	0.00875	CrCbGaD
Amcinonide—Dexamethasone—CYP2A6—prostate cancer	1.57e-05	0.00847	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—PTHLH—prostate cancer	1.57e-05	0.00047	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFBR1—prostate cancer	1.57e-05	0.00047	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF3H—prostate cancer	1.56e-05	0.000468	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	1.55e-05	0.000467	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKR1C3—prostate cancer	1.54e-05	0.000463	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKACB—prostate cancer	1.53e-05	0.00046	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP19A1—prostate cancer	1.5e-05	0.00807	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—THBS1—prostate cancer	1.49e-05	0.000449	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP3CA—prostate cancer	1.49e-05	0.000449	CbGpPWpGaD
Amcinonide—Triamcinolone—CYP3A4—prostate cancer	1.47e-05	0.00795	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	1.46e-05	0.000438	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKCZ—prostate cancer	1.44e-05	0.000434	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—prostate cancer	1.44e-05	0.00779	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—CTNNB1—prostate cancer	1.42e-05	0.000427	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	1.42e-05	0.000427	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CG—prostate cancer	1.41e-05	0.000424	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	1.41e-05	0.000423	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGFR4—prostate cancer	1.39e-05	0.000419	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PARP1—prostate cancer	1.39e-05	0.000419	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.39e-05	0.000418	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALCA—prostate cancer	1.38e-05	0.000414	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.37e-05	0.000411	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL12—prostate cancer	1.35e-05	0.000404	CbGpPWpGaD
Amcinonide—Prednisone—CYP3A4—prostate cancer	1.34e-05	0.00721	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.33e-05	0.000401	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.33e-05	0.0004	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—CYP3A4—prostate cancer	1.32e-05	0.00711	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CG—prostate cancer	1.28e-05	0.000385	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.28e-05	0.000383	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MBD2—prostate cancer	1.27e-05	0.000382	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TET2—prostate cancer	1.27e-05	0.000382	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP9—prostate cancer	1.27e-05	0.000381	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.25e-05	0.000376	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL12—prostate cancer	1.25e-05	0.000374	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CD—prostate cancer	1.24e-05	0.000373	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—STAT3—prostate cancer	1.24e-05	0.000373	CbGpPWpGaD
Amcinonide—Prednisolone—CYP3A4—prostate cancer	1.23e-05	0.00665	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.23e-05	0.000369	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.23e-05	0.000369	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKCQ—prostate cancer	1.23e-05	0.000369	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NGFR—prostate cancer	1.23e-05	0.000369	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAP3K7—prostate cancer	1.21e-05	0.000365	CbGpPWpGaD
Amcinonide—Dexamethasone—NR3C1—prostate cancer	1.21e-05	0.00654	CrCbGaD
Amcinonide—Betamethasone—CYP3A4—prostate cancer	1.21e-05	0.00651	CrCbGaD
Amcinonide—Betamethasone—PTGS2—prostate cancer	1.18e-05	0.00638	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.18e-05	0.000354	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.17e-05	0.000351	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF10—prostate cancer	1.17e-05	0.000351	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.17e-05	0.000351	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.16e-05	0.000347	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRB2—prostate cancer	1.15e-05	0.000347	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.15e-05	0.000345	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF3A—prostate cancer	1.14e-05	0.000344	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.14e-05	0.000343	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—JAK2—prostate cancer	1.14e-05	0.000342	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAP2K1—prostate cancer	1.13e-05	0.000341	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CD—prostate cancer	1.13e-05	0.000339	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VAV3—prostate cancer	1.13e-05	0.000338	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2E1—prostate cancer	1.12e-05	0.00602	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—TGFBR2—prostate cancer	1.11e-05	0.000333	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2C19—prostate cancer	1.1e-05	0.00596	CrCbGaD
Amcinonide—Dexamethasone—CYP1A1—prostate cancer	1.1e-05	0.00594	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—ITPR1—prostate cancer	1.09e-05	0.000328	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.08e-05	0.000325	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CB—prostate cancer	1.08e-05	0.000325	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.06e-05	0.000318	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1R—prostate cancer	1.04e-05	0.000314	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—prostate cancer	1.04e-05	0.000312	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—JAK2—prostate cancer	1.03e-05	0.000311	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LPL—prostate cancer	1e-05	0.000301	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2—prostate cancer	9.93e-06	0.000298	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDGFRB—prostate cancer	9.92e-06	0.000298	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CB—prostate cancer	9.82e-06	0.000295	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ITGB3—prostate cancer	9.67e-06	0.000291	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT3B—prostate cancer	9.62e-06	0.000289	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—prostate cancer	9.44e-06	0.000284	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL10—prostate cancer	9.44e-06	0.000284	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB3—prostate cancer	9.38e-06	0.000282	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGFR2—prostate cancer	9.36e-06	0.000281	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	9.26e-06	0.000278	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2—prostate cancer	9.02e-06	0.000271	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TERT—prostate cancer	8.99e-06	0.00027	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HIST1H4H—prostate cancer	8.95e-06	0.000269	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NPPA—prostate cancer	8.95e-06	0.000269	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	8.93e-06	0.000268	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MED12—prostate cancer	8.8e-06	0.000264	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—prostate cancer	8.66e-06	0.00026	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIF1A—prostate cancer	8.6e-06	0.000258	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—prostate cancer	8.39e-06	0.000252	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CAV1—prostate cancer	8.31e-06	0.00025	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KDR—prostate cancer	8.22e-06	0.000247	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	8.09e-06	0.000243	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ESR1—prostate cancer	8.01e-06	0.000241	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BAD—prostate cancer	7.82e-06	0.000235	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CG—prostate cancer	7.57e-06	0.000228	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APC—prostate cancer	7.57e-06	0.000228	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGF—prostate cancer	7.49e-06	0.000225	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IRS1—prostate cancer	7.49e-06	0.000225	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	7.49e-06	0.000225	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS19—prostate cancer	7.48e-06	0.000225	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GSK3B—prostate cancer	7.27e-06	0.000218	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—INS—prostate cancer	7.17e-06	0.000215	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT1—prostate cancer	7.15e-06	0.000215	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	7.09e-06	0.000213	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP3A4—prostate cancer	7.02e-06	0.00379	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—CREBBP—prostate cancer	7.02e-06	0.000211	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NCOA2—prostate cancer	7.02e-06	0.000211	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1—prostate cancer	6.93e-06	0.000208	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EZH2—prostate cancer	6.93e-06	0.000208	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—prostate cancer	6.9e-06	0.000207	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—prostate cancer	6.88e-06	0.00371	CrCbGaD
Amcinonide—NR3C1—Gene Expression—PARP1—prostate cancer	6.78e-06	0.000204	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAP2K1—prostate cancer	6.7e-06	0.000201	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CD—prostate cancer	6.66e-06	0.0002	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	6.65e-06	0.0002	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CA—prostate cancer	6.59e-06	0.000198	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SERPINE1—prostate cancer	6.59e-06	0.000198	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—prostate cancer	6.52e-06	0.000196	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA1A—prostate cancer	6.42e-06	0.000193	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR2—prostate cancer	6.42e-06	0.000193	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF2—prostate cancer	6.37e-06	0.000192	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOS3—prostate cancer	6.29e-06	0.000189	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JAK2—prostate cancer	6.11e-06	0.000184	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CA—prostate cancer	5.99e-06	0.00018	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MDM2—prostate cancer	5.96e-06	0.000179	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NCOA1—prostate cancer	5.92e-06	0.000178	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB2—prostate cancer	5.88e-06	0.000177	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CB—prostate cancer	5.8e-06	0.000174	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AR—prostate cancer	5.67e-06	0.00017	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RXRA—prostate cancer	5.63e-06	0.000169	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—prostate cancer	5.58e-06	0.000168	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1B—prostate cancer	5.45e-06	0.000164	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—prostate cancer	5.39e-06	0.000162	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—prostate cancer	5.34e-06	0.00016	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2—prostate cancer	5.33e-06	0.00016	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—prostate cancer	5.3e-06	0.000159	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCND1—prostate cancer	5.2e-06	0.000156	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SIRT1—prostate cancer	5.17e-06	0.000155	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CTNNB1—prostate cancer	5.14e-06	0.000155	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—VDR—prostate cancer	5.1e-06	0.000153	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—prostate cancer	5.04e-06	0.000152	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1A—prostate cancer	5.03e-06	0.000151	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—prostate cancer	5.01e-06	0.000151	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—prostate cancer	4.89e-06	0.000147	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EP300—prostate cancer	4.78e-06	0.000144	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ERCC2—prostate cancer	4.66e-06	0.00014	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SRC—prostate cancer	4.65e-06	0.00014	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—prostate cancer	4.53e-06	0.000136	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—prostate cancer	4.48e-06	0.000135	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARA—prostate cancer	4.3e-06	0.000129	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	4.21e-06	0.000126	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—prostate cancer	4.17e-06	0.000125	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—prostate cancer	4.16e-06	0.000125	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—prostate cancer	4.08e-06	0.000122	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR1—prostate cancer	3.89e-06	0.000117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—prostate cancer	3.85e-06	0.000116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CA—prostate cancer	3.54e-06	0.000106	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—prostate cancer	3.42e-06	0.000103	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CREBBP—prostate cancer	3.41e-06	0.000103	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SERPINE1—prostate cancer	3.2e-06	9.62e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—prostate cancer	3.13e-06	9.41e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—prostate cancer	2.89e-06	8.68e-05	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—prostate cancer	2.03e-06	6.09e-05	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—prostate cancer	1.4e-06	4.22e-05	CbGpPWpGaD
